Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G T McInnes

Showing results (111-120 of 114) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 114 results.
Lancet (London, England)|July 31, 1998
Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?A F Lever, D J Hole, C R Gillis, et al.
Journal of Hypertension|June 14, 2001
Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigatorsP S Sever, B Dahlöf, N R Poulter, et al.
The American Journal of Medicine|June 6, 1994
Comparison of lipid-lowering effects of low-dose fluvastatin and conventional-dose gemfibrozil in patients with primary hypercholesterolemiaD J Betteridge, P N Durrington, G J Fairhurst, et al.
Journal of Human Hypertension|November 1, 2001
Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocolP S Sever, B Dahlöf, N R Poulter, et al.
Pageof 12

Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
Lancet (London, England)|July 31, 1998
Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?A F Lever, D J Hole, C R Gillis, et al.
Journal of Hypertension|June 14, 2001
Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigatorsP S Sever, B Dahlöf, N R Poulter, et al.
The American Journal of Medicine|June 6, 1994
Comparison of lipid-lowering effects of low-dose fluvastatin and conventional-dose gemfibrozil in patients with primary hypercholesterolemiaD J Betteridge, P N Durrington, G J Fairhurst, et al.
Journal of Human Hypertension|November 1, 2001
Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocolP S Sever, B Dahlöf, N R Poulter, et al.
Pageof 12